Best GLP-1 telehealth, priced from the source

As of November 6, 2026, NexLife is our top GLP-1 telehealth pick, scoring 94 of 100 on our v4.1 rubric, with compounded tirzepatide at $115 a month on a 12-month plan, the same price at every dose, no membership fee and three named 503A pharmacies. Eden charges $129 a month for tirzepatide with no membership (read October 15, 2026); NexLife's month-to-month price is $129. NexLife ranks first because its price, inclusions and pharmacies are published in one place. Other providers are listed alphabetically until their v4.1 re-scores are done. Compounded tirzepatide is not FDA-approved.

Across the compounded tirzepatide programs we track, a year at the lowest printed standing rate is $1,548 at Eden ($129 a month, no membership; read October 15, 2026), $1,380 at NexLife on its 12-month plan (prices as of November 6, 2026) and $3,107 at Found ($239 per 28-day cycle, 13 cycles), and several programs cost more. The headline monthly price is rarely the whole cost. Membership fees, consultation fees, 28-day billing and prices that rise with the dose all change the yearly total. Our true-cost figures add every required charge a program publishes and name the charges it does not publish.

As of October 15, 2026, Eden charges $129 a month for compounded tirzepatide, every month with no membership and no dose-based increase, read from Eden's own weight-loss page, which says the price is not introductory. NexLife charges $115 a month on a 12-month plan and $129 month to month (prices as of November 6, 2026), and Lavender Sky Health's starter supply is $139. Some programs show "starting at" figures with a fee on top (IVIM: $117 plus a $75 monthly program fee) or per-dose entry prices (Mochi from $90 plus membership). This describes our index, not the whole market, and prices change often.

Of the GLP-1 telehealth programs we re-read on October 15, 2026, Mochi Health and IVIM Health add a fee to compounded medication: Mochi lists a membership of $199 for 12 months, and IVIM adds a $75 monthly program fee to tirzepatide that starts at $117. NexLife and Eden state no membership. Lavender Sky Health has no membership but charges $65 for the first consult and $40 per follow-up. Calibrate ($199 a month), Form Health ($299) and WeightWatchers Clinic ($74 on a 12-month plan) charge for the program only, so the medication is an extra cost.

A program that bills every 28 days charges 13 times a year instead of 12, so a $239 cycle price costs $3,107 over a year rather than the $2,868 that twelve monthly payments suggest, an extra $239 that the headline hides. As of October 15, 2026, Found prices compounded tirzepatide per 28-day cycle, and Enhance.MD bills its plans every 4, 12, 24 or 48 weeks. NexLife and Eden quote prices per month. To compare fairly, multiply a cycle price by 13, or by 365 divided by the cycle length in days, before you set it beside a monthly price.

Since July 1, 2026, people with Medicare Part D who meet the GLP-1 Bridge criteria can get Wegovy, Foundayo or the Zepbound KwikPen for a $50 monthly copayment through December 31, 2027, which is $600 a year and less than any cash-pay program we track. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, though their Part D plan might cover a GLP-1. Compounded drugs are not covered. Open Enrollment runs October 15 to December 7, 2026, and the Bridge needs Part D coverage, not a specific plan.